OptiBiotix Health Plc
OptiBiotix screening platforms:
OptiBiotix has developed a number of screening and technology platforms that can be utilised for Joint Development Projects.
A high throughput pharmaceutical screening platform to identify microbial metabolic pathways that interact with human pathways to improve health.
OptiBiotix has developed a proprietary high throughput screening and optimisation technology platform designed to identify microbes with metabolic pathways that can interact with human physiological processes and derive health benefits.
A high throughput screening platform, which generates novel oligosaccharides and screens them for their ability to modulate specific microbial genera or species and their microbial end products (short chain fatty acids such as acetate, propionate, butyrate) and physical properties (sweetness).
This process results in ‘designer prebiotics’ specific for a microbial target (genus/species) associated with a health benefit and has the ability to be used individually to modulate the microbiome or in combination with a probiotic to enhance the health benefit.
A high throughput technology platform that screens identifies and/or develops microbiome modulators, which can be used in proprietary formulations to benefit a wide range of lifestyle conditions.
OptiBiotix’s Lactobacillus plantarum LPLDL® is a next-generation probiotic that aids elements of cardiovascular and wellbeing.
What makes this product so distinctive is its ability to improve blood lipid profiles and blood pressure using probiotic research, a holistic, non-pharmaceutical solution, to transform the way physical health is approached. Whereas high levels of cholesterol are commonly addressed with statins, which are drugs known to be associated with a host of undesirable side effects, LPLDL® offers a natural, scientifically founded alternative with no known side effects.
LPLDL® has been shown in randomised, placebo controlled human intervention studies to deliver tangible health cardiovascular benefits and supporting overall heart wellness. These include:
- Improves total cholesterol
- Balances LDL and HDL cholesterol
- Supports nlrmal systolic blood pressure
- Be completely safe and well tolerated
*Independent studies have found LPLDL® to be safe and well tolerated by human subjects.
Transforming the way weight loss is traditionally approached, SlimBiome® offers a healthy, hunger-free weight management system that is backed by strong scientific principles rather than simply relying on willpower.
An award winning functional ingredient, SlimBiome® promotes the feeling of fullness, helps burn calories by promoting a healthy metabolism and maintains blood sugar levels to prevent overeating. It has been shown to reduce calorie intake by up to 20% and lower food cravings.
These natural prebiotic fibres called SweetBiotix® are patented, natural, low calorie alternatives to sugar that are calorie free with a clean flavour profile. Products under development include both intense prebiotic sweeteners and bulk sugar substitutes, suitable for wide range of sugar replacement applications in food and beverages.
An innovative dietary fibre concept, SweetBiotix® have the potential to address public health concerns over the impact of sugar on obesity, with the prospect of replacing ‘unhealthy’ sugars in existing products with low calorie, healthy non-digestible fibres.
CholBiome® is a unique range of supplements that use science-backed ingredients to help maintain healthy cholesterol levels, support normal blood pressure and promote heart wellness. CholBiome® is backed up by extensive testing and delivers real health benefits through science, naturally.
- International Probiotics Association (IPA)